329 related articles for article (PubMed ID: 31848852)
1. Biotransformation of the New Synthetic Cannabinoid with an Alkene, MDMB-4en-PINACA, by Human Hepatocytes, Human Liver Microsomes, and Human Urine and Blood.
Watanabe S; Vikingsson S; Åstrand A; Gréen H; Kronstrand R
AAPS J; 2019 Dec; 22(1):13. PubMed ID: 31848852
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Phase I Metabolism of the Recently Emerged Synthetic MDMB-4en-PINACA and Its Detection in Human Urine Samples.
Erol Ozturk Y; Yeter O
J Anal Toxicol; 2021 Jan; 44(9):976-984. PubMed ID: 32091101
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profiles and screening tactics for MDMB-4en-PINACA in human urine and serum samples.
Gu K; Qin S; Zhang Y; Zhang W; Xin G; Shi B; Wang J; Wang Y; Lu J
J Pharm Biomed Anal; 2022 Oct; 220():114985. PubMed ID: 35985137
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of MMB022 and identification of dihydrodiol formation in vitro using synthesized standards.
Watanabe S; Wu X; Dahlen J; Konradsson P; Vikingsson S; Kronstrand R; Gréen H
Drug Test Anal; 2020 Oct; 12(10):1432-1441. PubMed ID: 32608533
[TBL] [Abstract][Full Text] [Related]
5. The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons.
Kronstrand R; Norman C; Vikingsson S; Biemans A; Valencia Crespo B; Edwards D; Fletcher D; Gilbert N; Persson M; Reid R; Semenova O; Al Teneiji F; Wu X; Dahlén J; NicDaéid N; Tarbah F; Sutcliffe OB; McKenzie C; Gréen H
Drug Test Anal; 2022 Apr; 14(4):634-652. PubMed ID: 34811926
[TBL] [Abstract][Full Text] [Related]
6. In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry.
Presley BC; Logan BK; Jansen-Varnum SA
Drug Test Anal; 2019 Aug; 11(8):1264-1276. PubMed ID: 31108568
[TBL] [Abstract][Full Text] [Related]
7. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
[TBL] [Abstract][Full Text] [Related]
8. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens.
Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V
Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224
[TBL] [Abstract][Full Text] [Related]
9. Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection.
Carlier J; Diao X; Huestis MA
J Pharm Biomed Anal; 2018 Aug; 157():27-35. PubMed ID: 29754040
[TBL] [Abstract][Full Text] [Related]
10. 5F-MDMB-PICA metabolite identification and cannabinoid receptor activity.
Truver MT; Watanabe S; Åstrand A; Vikingsson S; Green H; Swortwood MJ; Kronstrand R
Drug Test Anal; 2020 Jan; 12(1):127-135. PubMed ID: 31461219
[TBL] [Abstract][Full Text] [Related]
11. The next generation of synthetic cannabinoids: Detection, activity, and potential toxicity of pent-4en and but-3en analogues including MDMB-4en-PINACA.
Krotulski AJ; Cannaert A; Stove C; Logan BK
Drug Test Anal; 2021 Feb; 13(2):427-438. PubMed ID: 32997377
[TBL] [Abstract][Full Text] [Related]
12. In Vivo Metabolites of AB-PINACA in Solid Tissues Obtained from Its Abuser: Comparison with In Vitro Experiment.
Minakata K; Hasegawa K; Yamagishi I; Nozawa H; Suzuki M; Kitamoto T; Suzuki O; Watanabe K
J Anal Toxicol; 2021 Jan; 44(9):1027-1035. PubMed ID: 32232365
[TBL] [Abstract][Full Text] [Related]
13. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
Yeter O; Ozturk YE
Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
[TBL] [Abstract][Full Text] [Related]
14. Rapid Identification of MDMB-CHMINACA Metabolites Using Zebrafish and Human Liver Microsomes as the Biotransformation System by LC-QE-HF-MS.
Xu DQ; Dai Y; Zhang WF; Wang JF; Wang YY; Zhang Y; Zhao QL; Li X
J Anal Toxicol; 2021 Jan; 44(9):1012-1026. PubMed ID: 32020177
[TBL] [Abstract][Full Text] [Related]
15. Systematic In Vitro Metabolic Profiling of the OXIZID Synthetic Cannabinoids BZO-4en-POXIZID, BZO-POXIZID, 5F-BZO-POXIZID, BZO-HEXOXIZID and BZO-CHMOXIZID.
Watanabe S; Baginski S; Iwai T; Matsushita R; Takatsu M; Nakanishi T; Lindbom K; Mckenzie C; Vikingsson S; Kronstrand R; Gréen H; Seto Y
J Anal Toxicol; 2023 May; 47(5):455-463. PubMed ID: 36857377
[TBL] [Abstract][Full Text] [Related]
16. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
[TBL] [Abstract][Full Text] [Related]
17. Detection and phase I metabolism of the 7-azaindole-derived synthetic cannabinoid 5F-AB-P7AICA including a preliminary pharmacokinetic evaluation.
Giorgetti A; Mogler L; Haschimi B; Halter S; Franz F; Westphal F; Fischmann S; Riedel J; Pütz M; Auwärter V
Drug Test Anal; 2020 Jan; 12(1):78-91. PubMed ID: 31476105
[TBL] [Abstract][Full Text] [Related]
18. A Systematic Study of the In Vitro Pharmacokinetics and Estimated Human In Vivo Clearance of Indole and Indazole-3-Carboxamide Synthetic Cannabinoid Receptor Agonists Detected on the Illicit Drug Market.
Brandon AM; Antonides LH; Riley J; Epemolu O; McKeown DA; Read KD; McKenzie C
Molecules; 2021 Mar; 26(5):. PubMed ID: 33807614
[TBL] [Abstract][Full Text] [Related]
19. Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA.
Wohlfarth A; Castaneto MS; Zhu M; Pang S; Scheidweiler KB; Kronstrand R; Huestis MA
AAPS J; 2015 May; 17(3):660-77. PubMed ID: 25721194
[TBL] [Abstract][Full Text] [Related]
20. Human phase-I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F-EDMB-PICA and EDMB-PINACA.
Giorgetti A; Brunetti P; Haschimi B; Busardò FP; Pelotti S; Auwärter V
Drug Test Anal; 2023 Mar; 15(3):299-313. PubMed ID: 36366743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
